Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Luye Pharma Of China To Be Sold To Investment Firm For $140 Million

This article was originally published in PharmAsia News

Executive Summary

China’s Luye Pharmaceutical Investment, which owns about 77% of Luve Pharma Group, is about to undergo a change of ownership, with South Korea’s MBK Partners agreeing to sell more than half its shares of the drug maker to three investment firms.

Topics

UsernamePublicRestriction

Register

SC080587

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel